IL91482A0 - Pharmaceutical compositions containing certain heterocyclic compounds - Google Patents

Pharmaceutical compositions containing certain heterocyclic compounds

Info

Publication number
IL91482A0
IL91482A0 IL91482A IL9148289A IL91482A0 IL 91482 A0 IL91482 A0 IL 91482A0 IL 91482 A IL91482 A IL 91482A IL 9148289 A IL9148289 A IL 9148289A IL 91482 A0 IL91482 A0 IL 91482A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
heterocyclic compounds
containing certain
certain heterocyclic
Prior art date
Application number
IL91482A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL91482A0 publication Critical patent/IL91482A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL91482A 1988-09-01 1989-08-31 Pharmaceutical compositions containing certain heterocyclic compounds IL91482A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888820651A GB8820651D0 (en) 1988-09-01 1988-09-01 Medicaments

Publications (1)

Publication Number Publication Date
IL91482A0 true IL91482A0 (en) 1990-04-29

Family

ID=10643003

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91482A IL91482A0 (en) 1988-09-01 1989-08-31 Pharmaceutical compositions containing certain heterocyclic compounds

Country Status (10)

Country Link
EP (1) EP0357415A3 (de)
JP (1) JPH02180824A (de)
KR (1) KR900004340A (de)
AU (1) AU627769B2 (de)
CA (1) CA1330536C (de)
DK (1) DK432689A (de)
GB (1) GB8820651D0 (de)
IL (1) IL91482A0 (de)
PH (1) PH26968A (de)
ZA (1) ZA896675B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276050A (en) * 1989-08-01 1994-01-04 Glaxo Group Limited Medicaments
EP0492020A1 (de) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Verwendung von bestimmten Estern von Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-on und verwandter Verbindungen zur Behandlung von kognitiven Erkrankungen
DK148292D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Forbindelser
WO1994020102A2 (en) * 1993-03-08 1994-09-15 Fujisawa Pharmaceutical Co., Ltd. Medicament for treating or preventing cerebrovascular diseases
GB0305553D0 (en) * 2003-03-11 2003-04-16 Glaxo Group Ltd Compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
US4624961A (en) * 1985-04-17 1986-11-25 A. H. Robins Company, Incorporated Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
IE60991B1 (en) * 1986-12-17 1994-09-07 Glaxo Group Ltd Use of ketone derivatives in the treatment of cognitive disorders
EP0279990B1 (de) * 1986-12-17 1995-07-12 Glaxo Group Limited Verwendung von heterocyclischen Verbindungen zur Behandlung von Bewusstseinsstörungen
GB2209335B (en) * 1987-09-03 1991-05-29 Glaxo Group Ltd Lactam derivatives

Also Published As

Publication number Publication date
KR900004340A (ko) 1990-04-12
DK432689A (da) 1990-03-02
AU4096789A (en) 1990-03-08
JPH02180824A (ja) 1990-07-13
EP0357415A2 (de) 1990-03-07
ZA896675B (en) 1990-09-26
CA1330536C (en) 1994-07-05
PH26968A (en) 1992-12-28
EP0357415A3 (de) 1990-08-08
DK432689D0 (da) 1989-08-31
GB8820651D0 (en) 1988-10-05
AU627769B2 (en) 1992-09-03

Similar Documents

Publication Publication Date Title
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
GB2222772B (en) Pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
CY1574A (en) Pharmaceutical compositions containing 1-hydroxypyramid-2-one derivatives
NZ224347A (en) Heterocyclic compounds and pharmaceutical compositions
IL92837A0 (en) 7-oxabicycloheptyl substituted heterocyclic prostaglandin analogs and pharmaceutical compositions containing the same
EP0403578A4 (en) Stable pharmaceutical composition
IL87435A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL90639A (en) Neplanocin derivatives and analogs and pharmaceutical compositions containing them
IL106385A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
GB8417170D0 (en) Heterocyclic pharmaceutical compounds
IL87494A0 (en) Pharmaceutical compositions containing benzylpyrimidine derivatives
IL106041A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL92314A0 (en) Pharmaceutical compositions containing azepinones
IL91482A0 (en) Pharmaceutical compositions containing certain heterocyclic compounds
IL86437A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives
IL91480A0 (en) Pharmaceutical compositions containing certain heterocyclic compounds
IL91481A0 (en) Pharmaceutical compositions containing certain heterocyclic compounds
IL89049A0 (en) Pharmaceutical composition containing 4-aroylimidazol-2-ones
IL87444A0 (en) Pharmaceutical compositions containing polyaromatic compounds
IL91350A0 (en) Phenylalkylthiophenes and related compounds and pharmaceutical compositions containing them
IL84857A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives
GB2217202B (en) Trimelamol-containing pharmaceutical compositions
NZ214764A (en) Heterocyclic compounds and pharmaceutical compositions